Receptor-Interacting Serine/Threonine-Protein-Kinase-2 as a Potential Prognostic Factor in Colorectal Cancer
*Corresponding Author:
Copyright: © 0 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
To read the full article Peer-reviewed Article PDF 
Abstract
Receptor-interacting-serine/threonine-protein-kinase-2(RIPK2) is an important mediator in different pathways in the immune and inflammatory response system. RIPK2 was also shown to play different roles in different cancer types, however, in Colorectal Cancer(CRC); its role is not well established. This study aims at identifying the role of RIPK2 in CRC progression and survival.
